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A hybrid lipid membrane coating “shape-locks”
silver nanoparticles to prevent surface oxidation
and silver ion dissolution†
Thomas J. Miesen, Arek M. Engstrom, Dane C. Frost, Ramya Ajjarapu,
Rohan Ajjarapu, Citlali Nieves Lira and Marilyn R. Mackiewicz *
The controlled synthesis of stable silver nanoparticles (AgNPs), that do not undergo surface oxidation and
Ag+ ion dissolution, continues to be a major challenge. Here the synthesis of robust hybrid lipid-coated
AgNPs, comprised of L-a-phosphatidylcholine (PC) membranes anchored by a stoichiometric amount of
long-chained hydrophobic thiols and sodium oleate (SOA) as hydrophobic binding partners, that do not
undergo surface oxidation and Ag+ ion dissolution, is described. UV-Visible (UV-Vis) spectroscopy,
transmission electron microscopy (TEM), and inductively coupled plasma mass spectrometry (ICP-MS)
demonstrate that in the presence of strong oxidants, such as potassium cyanide (KCN), the hybrid lipid-
coated AgNPs are stable and do not undergo surface oxidation even in the presence of membrane
destabilizing surfactants. UV-Vis studies show that the stability of hybrid lipid-coated AgNPs of various
sizes and shapes is dependent on the length of the thiol hydrocarbon chain and can be ranked in the
order of increasing stability as follows: propanethiol (PT) < hexanethiol (HT) # decanethiol (DT). UV-Vis
and ICP-MS studies show that the hybrid lipid-coated AgNPs do not change in size or shape confirming
that the AgNPs do not undergo surface oxidation and Ag+ ion dissolution when placed in the presence
of strong oxidants, chlorides, thiols, and low pH. Long-term stability studies, over 21 days, show that the
hybrid lipid-coated AgNPs do not release Ag+ ions and are more stable. Overall, these studies
demonstrate hybrid membrane encapsulation of nanomaterials is a viable method for stabilizing AgNPs
in a “shape-locked” form that is unable to undergo surface oxidation, Ag+ ion release, aging, or shape
conversion. More importantly, this design strategy is a simple approach to the synthesis and stabilization
of AgNPs for a variety of biomedical and commercial applications where Ag+ ion release and toxicity is
a concern. With robust and shielded AgNPs, investigators can now evaluate and correlate how the
physical features of AgNPs influence toxicity without the confounding factor of Ag+ ions present in
samples. This design strategy also provides an opportunity where the membrane composition can be
tuned to control the release rate of Ag+ ions for optimizing antimicrobial activity.
Introduction
Engineered nanomaterials are used for a wide range of applica-
tions in many different elds and are a rapidly growing tech-
nology.1–3 Every year about 500 tons of silver nanoparticles
(AgNPs) are produced for many industrial and biomedical appli-
cations because of their unique optical, chemical, physical, bio-
logical, catalytic, and broad-spectrum antimicrobial activity.4–15
Harnessing their antimicrobial power, AgNPs are incorporated
into food packaging,1–3 clothing,16–18 and inmedical products such
as wound gels,19,20 bandages,21–23 coatings on medical cathe-
ters,24,25 and cardiovascular implants.15,26,27 In addition, AgNPs are
utilized in various subelds of medicine as plasmonic antennas,
diagnostic agents, and as nanoprobes to target and image small
molecules such as DNA, proteins, cell tissue, and tumors.28–30
Because AgNPs exhibit a red-shi in the plasmonic extinction
band in the near-infrared (NIR) optical window region (700–900
nm), they are also used as imaging and photothermal agents to
visualize and destroy cancer cells.31,32 Their wide applicability and
versatility have led to an increased demand for optimized AgNPs
with tuned physical, optical, and chemical properties for various
applications. More importantly, biocompatible and stable AgNPs
with minimal impact on human health and the environment are
of signicant interest.
It is well-known that the physical, optical, and catalytic
properties of AgNPs are strongly inuenced by their size, shape,
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and surface properties and can be optimized using various
synthetic methods, reducing agents, and stabilizers.33–37
Synthetic methods for AgNP synthesis include physical
methods, such as evaporation–condensation techniques38,39 or
laser ablation,40 and chemical methods where metal salts are
reduced in the presence of capping agents.41–45 Depending on
the capping agent used in chemical synthesis, AgNPs can be
dispersed in aqueous or organic solvents and stabilized to
minimize aggregation either by steric or electrostatic repulsion.
Ligands used as capping agents include citrate, halides,
carboxylates, amines, and polyoxoanions that produce AgNPs
with anionic or cationic charge, while polymers such as poly N-
vinyl-2-pyrrolidone (PVP), polyethylene glycol (PEG), poly-
methacrylic acid (PMAA), polymethylmethacrylate (PMMA) and
dodecanethiol allow for steric repulsion to prevent AgNP
aggregation.42,46 Chemical methods also allow for a wide variety
of reducing agents such as glucose, hydrazine, ascorbate,
ethylene glycol, citrate, dimethylformamide, dextrose, and
sodium borohydride (NaBH4) to control the rate of reduction
and formation of AgNPs of various size and shapes.47,48
Although these synthetic methods have produced AgNPs sha-
ped as spheres,49 cubes,50 bipyramids,51 stars,52 nanoprisms,53
triangular plates53 these methods are energy-intensive, the size
and shape distributions are not always homogenous, and
chemicals used can be toxic. Consequently, this has given rise to
alternative green synthetic approaches employing biological
entities such as microorganisms10,12,54,55 and plant extracts4,56–63
to replace more complex syntheses of AgNPs free from toxic
capping agents and hazardous byproducts.
While these synthetic strategies tune specic physical,
optical, and chemical properties, other critical parameters
remained largely unexplored. For example, there are very few
methods that focus on control of surface oxidation, Ag+ ion
dissolution, and AgNP shape conversion in both biological and
environmental media conditions. Consequently, the inability to
control these critical parameters limits the long-term stability,
shelf-life and use of AgNPs in commercial and biomedical
applications where nanomaterial degradation, Ag+ ion release,
and toxicity is a challenge and concern. For instance, in anti-
bacterial applications, the controlled release of Ag+ ions is
a highly desirable property of AgNPs for optimal antimicrobial
activity in addition to size, shape, surface charge, concentra-
tion, and colloidal state.51–54 However, there are applications
where the presence of Ag+ ions is not always desirable. For
example, toxicology studies with AgNPs have shown associated
cytotoxicity, genotoxicity, and inammatory response in
plants,64 zebrash embryos,65 and mammalian cell culture
models,66–69 thereby raising concerns about the potential envi-
ronmental and human health risks of AgNPs. In these studies,
Ag+ ions are always present and is a confounding factor making
it difficult to interpret data and elucidate how the physico-
chemical features, shape, size, surface chemistry, and surface
area of AgNPs inuence toxicity. That is when surface oxidation
and Ag+ ion dissolution lead to changes in shape and size it is
difficult to effectively assess how size or shape inuences
toxicity. Toxicology studies are limited by the lack of well-
controlled and stable AgNP batches of varying size, shape,
surface area, and charge without Ag+ ions. Accordingly, there is
a great need for alternative design approaches for the synthesis
of well-dened AgNPs without Ag+ to assess the fate, biouptake,
and ecotoxicity of AgNPs.
Other applications where the presence of Ag+ ions is
unwanted include those where AgNPs are used as imaging
agents for X-ray CT,70,71 photoacoustic,72 and optical coherence
tomography (OCT)73 or incorporated into devices such as
orthopedic implants,74 or used as drug delivery vehicles.75,76
AgNP-based imaging agents that undergo surface oxidation and
Ag+ ion dissolution result in a change in the size and shape,
which are physicochemical features that affect the optical and
light scattering properties of AgNPs.77,78 Besides, when AgNP-
based drug delivery agents undergo surface oxidation and Ag+
ion dissolution, AgNPs become unstable, have short shelf-life,
undergo premature drug release, and induce toxicity. There-
fore, in these types of applications, robust AgNPs that do not
undergo surface oxidation and Ag+ ion release are of paramount
importance to minimize any human health and safety concerns.
To protect the AgNPs from surface oxidation and instability,
AgNPs have been modied with covalent organic ligands such
as polyvinylpyrrolidone (PVP),64 lipids,70 and polyethylene glycol
(PEG),79–82 or thiolated PEG83 as well as inorganic substrates
such as gold79 or silica core–shell.84,85 Alloys comprised of silver,
gold, and chromium have also been shown to enhance the
stability of AgNPs79,86 or other metal oxides.87 Depending on the
type of AgNPs and method of surface protection, stability
studies show that the AgNPs are stable from 1 week to 100 days
without a change in the size or shape in water or citrate
buffer.70,79,86 AgNPs with the organic surface coating are not very
stable for long periods compared to those with an inorganic
surface layer that shields the AgNP core. These design strategies
are great steps towards controlling Ag+ ion dissolution and
preventing AgNPs from undergoing surface oxidation in
a variety of media. However, these methods require more than
one step, are complicated, and are limited to one shape or size
of AgNPs. In addition, the organic ligands are not as protective
and might limit their use in different applications. Opportuni-
ties remain for simple and inexpensive methods with few steps
to produce versatile, stable, and biocompatible AgNPs of
varying size and shape that do not undergo surface oxidation,
Ag+ ion release, and shape conversion.
In this study, a simple, innovative, and versatile approach to
the design of water-soluble AgNPs that are differentially shiel-
ded from surface oxidation and Ag+ ion dissolution is described.
These AgNPs have a bioorganic surface coating comprised of
natural lipid membranes that are anchored to the AgNP surface
by a stoichiometric number of hydrophobic thiols (Scheme 1).
These hybrid lipid-coated AgNPs and their stability were char-
acterized and evaluated using UV-Visible (UV-Vis) spectroscopy,
inductively coupled plasma mass spectrometry (ICP-MS), and
transmission electron microscopy (TEM) to demonstrate that
the hybrid lipid membrane shields the AgNP to prevent surface
oxidation, Ag+ ion release, and shape or size conversion. The
hybrid lipid-membrane coating is adaptable and can be used to
coat AgNPs of varying size and shape for controlled release or no
release of Ag+ ions. A wide variety of commercially available

































































































lipids with different functional groups, conjugated dyes or
drugs, and other ligands can be used to coat the AgNPs. This
adaptable design allows one to produce a library of membrane-
coated AgNP with tuned surface chemistry and optical proper-
ties for a variety of applications. For example, the hybrid lipid-
coated AgNPs can be used in clinical applications where
AgNPs are used as drug delivery and bioimaging agents and
where degradation of AgNPs from surface oxidation, Ag+ ions,
shape conversion is unwanted. Furthermore, robust AgNPs that
do not release Ag+ ions are now available for toxicological
studies where the effect of shape, size, and surface area on
toxicity can be studied.
Results and discussion
Preparation of shaped-locked silver nanoparticles (AgNPs)
Previously we showed that hybrid lipid-coated gold nano-
particles (AuNPs) have unique stability in the presence of strong
etchants such as cyanide (CN)88–91 when compared to other
AuNPs with less robust coatings, such as citrate and thiols, that
typically undergo rapid oxidation in the presence of CN.92–94 In
addition to hybrid lipid-coated AuNPs, traditionally AuNPs are
more stable to oxidation compared to silver nanoparticles
(AgNPs) that are not as stable and undergo surface oxidation
readily. Therefore, to test the versatility of hybrid lipid
membranes as a strategy to stabilize AgNPs, citrate-capped
AgNPs are coated with the hybrid lipid membranes to shield
them from surface oxidation (Ag0 / Ag+) and Ag+ ion release.
The synthesis begins with the use of citrate-capped AgNPs of
various sizes and shapes that are prepared using a modied
procedure previously reported in the absence of poly-
vinylpyrrolidone (PVP).78,95–97 Briey, varying amounts of NaBH4
are added to a solution containing a mixture of AgNO3, sodium
citrate, and H2O2 to generate spheres, rods, and triangular-
shaped AgNPs. UV-Vis show a characteristic narrow localized
surface plasmon resonance (LSPR) band at 405 nm for spherical
AgNPs (Fig. 1A(i)) with an average diameter of 9.9 nm  4.4 nm
as measured by TEM (Fig. 1B and S1A†) from 607 spherical
nanoparticles. The UV-Vis spectra taken of rod-shaped AgNPs
show a small characteristic shoulder LSPR at 408 nm and more
intense band at 558 nm (Fig. 1A(ii)) with an average width of 5.9
 1.0 nm and length 20  5.6 nm as measured by TEM (Fig. 1C
and S1C†) from 232 nanorods. Similarly, triangular-shaped
AgNPs had characteristic a small shoulder LSPR band at
440 nm and an intense band 647 nm with an average length of
32  7.1 nm (Fig. 1D and S1B†) that was determined by
measuring the edge length of the triangular-shaped AgNPs from
the apex of the triangle to the base on all three sides of 527
nanoparticles (Fig. 1D). TEM also shows that the solutions of
rod and triangular-shaped nanoparticles are not homogeneous
in size and morphology (Fig. 1C and D) and contain mixtures
comprised of spheres, triangles, and rods as evidenced by the
broadness of the LSPR band. Analysis of TEM images showed
that the triangular-shaped nanoparticle solutions are
comprised of 35% spheres, 1% rods, and 64% triangles. There
were many overlapping AgNPs in the rod-shaped solutions from
the TEM imaging making it difficult to assess the percent of
each type of shape present.
Using these citrate-capped AgNPs, a layer-by-layer assembly
approach is used to encapsulate and stabilize bilayer liposomes
around the AgNP core of various shapes and sizes. The rst step
to the layer-by-layer assembly involves the addition of sodium
oleate (SOA), which acts as a hydrophobic binding partner to the
hydrophobic thiol added in the last stage of the assembly to
prevent AgNP aggregation (Scheme 1). The addition of SOA is
followed by the addition of preformed liposomes comprised of
zwitterionic PC lipids that keep the AgNPs soluble in an
aqueous environment. In addition, unlike other syntheses of
lipid-coated nanoparticles where an excess of lipids is used
during the coating process, these hybrid lipid-coated AgNPs are
prepared with minimal lipids to cover the surface of each
nanoparticle of a given shape and diameter. This strategy
minimizes the formation of “nanoparticle-free” liposomes and
reduces the number of purication steps of the materials aer
synthesis. The last stage of the assembly involves the addition of
a hydrophobic thiol such as propanethiol (PT), hexanethiol (HT)
or decanethiol (DT) to form the hybrid-lipid-coated AgNPs. The
number of lipids, SOA, and thiols estimated around each AgNP
is based on the size and shape (see ESI†).
UV-Vis show that the addition of various ligands (SOA, PC,
thiol) to the citrate-capped AgNPs leads to a slight red-shi in
the LSPR band of the AgNPs of varying shapes and sizes. For
example, a 29 nm red-shi is observed upon the formation of
the triangular-shaped Ag-SOA-PC-DT nanoparticles aer layer-
by-layer assembly (Fig. 2) The change in the LSPR band is
indicative of a change in the index of refraction of the AgNPs
upon displacement of the citrate ligands with SOA, PC, and
thiol ligands (Scheme 1). Since the Ag-SOA-PC-DT remains
Scheme 1 Assembly of robust hybrid lipid-coated AgNPs.

































































































soluble in an aqueous environment, this suggests that a bilayer
is formed around the AgNP core whereby the zwitterionic polar
headgroups of the second lipid layer is oriented away from the
surface to interact with water molecules. Note that the addition
of a stoichiometric amount of thiol does not result in any
signicant etching of the AgNP core as indicated by a lack of
blue-shi in the LSPR band (Fig. 2(iii)).
Evidence of complete membrane coverage of AgNPs
To determine if the AgNPs are completely covered by lipid
membranes and to examine their stability in the presence of
oxidants, hybrid lipid-coated AgNPs were exposed to CN,
which is known to oxidize metals such as Au0 and Ag0 to Au3+ or
Ag+, respectively.98,99 Briey, CN is added to a 1 mL solution of
triangular-shaped AgNPs (1.2 Optical Density (O.D.)) and the
UV-Vis spectra recorded before and aer CN addition (Fig. 3).
When CN is added to Ag-SOA-PC with no thiol ligands an
immediate decrease in the LSPR band is observed (Fig. 3(i)),
while no signicant decrease in the SPR is observed over 24 h
with Ag-SOA-PC-HT containing SOA, PC, and thiols, (Fig. 3(ii)
and (iii)) or Ag-SOA-HT containing, SOA and thiols, (Fig. S2(ii)†).
The lack of change in the LSPR band indicates that the AgNP
surface is completely covered by lipids, thiols, and SOA mole-
cules in a tightly packed arrangement such that CN ions are
not able to penetrate the bilayer to etch the AgNP surface and is
similar to that observed with hybrid lipid-coated AuNPs.88–91
Although both the Ag-SOA-HT and Ag-SOA-PC-HT are found to
be stable in the presence of CN, AgNPs with a combination of
SOA, PC, and thiols are more soluble and stable (vide infra) long-
term compared to AgNPs with SOA and thiols only. Similar
protection of the AgNP surface is offered to spherical and rod-
shaped hybrid lipid-coated AgNPs that do not undergo surface
oxidation or shape conversion (Fig. S3†). To the best of our
knowledge, this is the rst time AgNPs of varying shapes and
sizes have been shape-locked and shielded from surface
Fig. 1 (A) Representative UV-vis spectra of (i) spherical, (ii) rod-shaped, and (iii) triangular-shaped citrate-capped AgNPs in H2O. Representative
TEM micrographs of (B) spherical, (C) rod, and (D) triangular-shaped citrate-capped AgNPs with a reference to how measurements were taken
(x). Scale bar ¼ 20 nm.
Fig. 2 Representative UV-Vis spectra showing the layer-by-layer
assembly of 1 mL of triangular-shaped AgNPs (1.0 optical density
(O.D.)) comprised of (i) Ag-citrate (blue), (ii) Ag-citrate-SOA (orange),
(iii) Ag-citrate-SOA-PC (green), and (iv) Ag-citrate-PC-SOA-DT
(purple) in H2O.

































































































oxidation and Ag+ ion release using a hybrid lipid membrane
coating. This design strategy, using thiol ligands as anchors is
versatile and can be used to stabilize AgNPs from surface
oxidation to produce robust AgNP platforms that can be
employed for use in a variety of biomedical applications and for
use in toxicological studies without the presence of Ag+ ions as
a confounding factor thereby minimizing their toxicity.
Impact of thiol chain length and surfactants on the stability of
lipid-coated AgNPs
Previous studies showed that the length of the hydrocarbon
backbone of the thiol and structure impacts the stability of
hybrid lipid-coated AuNPs.89 Similarly, to investigate if the thiol
chain length impacts the stability and robustness of hybrid
lipid-coated AgNPs, samples of Ag-SOA and Ag-SOA-PC are
incubated with thiols (PT, HT, and DT). CN is then added to
each of these hybrid lipid-coated AgNPs and the change in the
LSPR and O.D. monitored (Fig. 4). Representative UV-Vis
spectra of Ag-SOA-thiol and Ag-SOA-PC-thiol samples before
and aer CN addition show a signicant red-shi in the LSPR
band and decrease in O.D. with Ag-SOA-PT (33% D in LSPR
and 95% D in O.D.) and Ag-SOA-PC-PT (15% D in LSPR and
48% D in O.D.). In contrast, minimal change in the LSPR and
O.D. of Ag-SOA-HT (6%D in LSPR and 12%D in O.D.), Ag-SOA-
PC-HT (3%D in LSPR and7% D in O.D.), Ag-SOA-DT (2%D
in LSPR and 2% D in O.D.), Ag-SOA-PC-DT (2% D in LSPR
and 3% D in O.D.) is observed (Fig. 4). Overall, the Ag-SOA-
thiol nanoparticles are found to be less stable than the Ag-
SOA-PC-thiol nanoparticles demonstrating that the hybrid
bilayer protects the surface from strong oxidants and keeps
them stable in aqueous media.
This study conrms that long-chain hydrophobic thiols
provide greater stability to the nanoparticles by helping to
anchor the membranes close to the AgNP surface in a tight
packing arrangement (Scheme 2A). In contrast, the short-
chained PT is unable to fully interdigitate into the lipid
bilayer to interact with the hydrophobic lipid tails to anchor the
membrane close to the AgNP core (Scheme 2B). Hence, Ag-SOA-
PC-PT nanoparticles are susceptible to surface oxidation and
CN etching (Fig. 4). A ranking of the AgNP stability in the
presence of CN with thiols of varying chain lengths from
greatest to least stable are DT $ HT > PT and is consistent with
previous work.89 These studies show that differentially shielded
nanoparticles can be prepared by varying the thiol chain lengths
to control the release of Ag+ ions.
To further test the robustness of the hybrid lipid-coated
AgNPs against susceptibility to surface oxidation, nanoparticle
samples were exposed to a well-known membrane disrupting
surfactant, TWEEN®20. To ensure that liposome disruption
occurred, four times the critical micelle concentration (CMC) of
TWEEN®20 (PC : TWEEN®20 ratio is 1 : 15) was incubated for
30 min with a 1 mL sample of triangular-shaped Ag-SOA-PC-PT
or Ag-SOA-PC-HT nanoparticles of 1.0 O.D. in H2O. Samples are
exposed to CN and monitored by UV-Vis spectroscopy over 1
week (Fig. 5). Minimal change in the O.D. (<1%) is observed
upon the addition of TWEEN®20 to Ag-SOA-PC-HT with the
long-chained hydrophobic thiol (Fig. 5A(ii)), while a signicant
change (>98%) is observed Ag-SOA-PC-PT with the short-
chained thiol (Fig. 5B(ii)). An additional 40–51% decrease in
O.D. is observed with Ag-SOA-PC-PT in the presence of
TWEEN®20 and CN when compared to Ag-SOA-PC-PT and Ag-
SOA-PT in the presence of CN and absence of TWEEN®20. This
indicates that TWEEN®20 can disrupt the structural integrity of
the membrane surrounding Ag-SOA-PC-PT to enable greater
Fig. 3 Representative UV-vis spectra of triangular-shaped Ag-SOA-
PC-HT (O.D. ¼ 1.2) (i) before and (ii) after the addition of KCN, and (iii)
Ag-SOA-PC after KCN in 10 mM sodium phosphate buffer pH 8.
Fig. 4 Representative |% change| in the (A) LSPR band and (B) O.D. of Ag-SOA-thiol (blue) or Ag-SOA-PC-thiol (orange) nanoparticles 24 h after
the addition of 20 mL of 307 mM KCN in 10 mM sodium phosphate buffer pH 8. DT ¼ decanethiol, HT ¼ hexanethiol, and PT ¼ propanethiol.

































































































penetration of CN for etching. Most importantly, this study
suggests that membrane disrupting surfactants are unable to
disrupt the structural integrity of hybrid lipid membranes that
are tightly packed with long-chained hydrophobic thiols (Ag-
SOA-PC-HT) (Scheme 2A) and completely shields the AgNP
surface from oxidation and Ag+ ion dissolution.
Long-term storage stability and Ag+ ion dissolution
The control of Ag+ dissolution is an important feature of AgNPs
that denes their use as antimicrobials, drug delivery, imaging
agents, and toxicity studies. Therefore, it is important to eval-
uate the long-term storage of AgNPs and their ability to undergo
Ag+ ion release via surface oxidation over time. UV-Vis spec-
troscopy and ICP-MS was used to study the long-term stability of
the most stable triangular-shaped Ag-SOA-thiol and Ag-SOA-PC-
X (thiol ¼ PT, HT, DT) platforms. Briey, the UV-Vis spectra
were recorded for AgNP platforms prepared and stored in H2O
in the dark at 25 C over 2 months under aerobic conditions
(Fig. 6). The % change in the O.D. (Fig. 6A and B) and LSPR
(Fig. S4†) of Ag-SOA-PC-X (X ¼ PT, HT, DT) is minimal aer 21
days of storage indicating that hybrid lipid-coated AgNPs are
stable and soluble with no surface oxidation, Ag+ ion dissolu-
tion, or shape conversion. TEM studies of a 2 month-old sample
of triangular-shaped Ag-SOA-PC-HT showed an average edge
length of 38  9.4 nm of 547 nanoparticles that was similar to
a fresh batch of AgNPs conrming that the shape did not
change (Fig. 6C and D). While the Ag-SOA-DT and Ag-SOA-HT
nanoparticles with no PC remained stable aer 21 days,
a 23% change in O.D. is observed for the Ag-SOA-PT platforms
aer 24 h followed by an additional 30% change in O.D. aer 21
days. Similar changes are observed in the LSPR band of the Ag-
SOA-PT conrming that these AgNPs are not as stable as the
hybrid lipid-coated AgNPs (Fig. S4†). Ag-SOA-PT shows visible
signs of aggregation as evidenced by a noticeable dark precip-
itate in the vial and loss of color, indicating that the Ag-SOA-PT
underwent aggregation and surface oxidation. This is not
surprising as short-chained alkanethiols are known to etch
metal nanoparticles making the AgNPs less stable.100
ICP-MS studies were performed to conrm that Ag-SOA-PC-
HT did not undergo surface oxidation and Ag+ ion dissolu-
tion. Samples of spherical and triangular-shaped Ag-Cit, Ag-
Scheme 2 Cartoon of hybrid lipid-membrane composition around AgNP core containing (A) decanethiol (DT) and (B) propanethiol (PT).
Fig. 5 A comparison of the percent change in the O.D. of (A) Ag-SOA-HT and Ag-SOA-PC-HT (i), and Ag-SOA-PC-HT with TWEEN®20 (ii), and
(B) Ag-SOA-PT, Ag-SOA-PC-PT (i), and Ag-SOA-PC-PT with TWEEN®20 (ii). All samples are monitored for 1 week post-KCN addition. The final
concentration of TWEEN®20 in all samples is 0.2 mM.

































































































SOA-PC, Ag-SOA-PC-PT, and Ag-SOA-PC-HT were prepared in
H2O, puried by ultracentrifugation to remove any unreacted
trace Ag+ ions from the initial synthesis, and stored in the dark
at 25 C for 1 week. At each time point, 1 mL of spherical AgNP
(1.2 O.D.) or triangular AgNPs (0.8 O.D.) samples were retrieved,
ltered by ultracentrifugation using Vivaspin columns with PES
membrane with a molecular weight cut-off (MWCO) of 3 kDa at
4700 rpm for 4 min, and the ltrate collected for ICP-MS anal-
ysis. Filtrates retrieved at all time points show the presence of
Ag+ ions for spherical and triangular-shaped Ag-Cit and Ag-Cit-
SOA-PC nanoparticles within 1 h, 24, and 1 week (Fig. 7 and
Tables S1, S2†). The Ag-SOA-PC shows the greatest amount of
Ag+ ion release because the SOA and the PC are not covalently
attached making these nanoparticles more prone to surface
oxidation compared to the citrated-capped AgNPs where the
citrate oxygen groups are covalently attached. Additionally,
spherical AgNPs releasedmore Ag+ ions compared to triangular-
shaped AgNPs and is reasonable since spherical AgNPs have
a larger surface to volume ratio and larger concentration of
AgNPs compared to the triangular-shaped AgNPs. Not surpris-
ingly, the hybrid lipid-coated AgNPs, Ag-SOA-PC-HT and Ag-
SOA-PC-PT, showed minimal or no Ag+ release over 1 week
(Fig. 7 and Tables S1, S2†). The ICP-MS studies are consistent
with the UV-Vis studies showing minimal % change of the O.D.
(Fig. 6) and LSRP band (Fig. S5†) and are found to be similar for
both spherical and triangular-shaped AgNPs. This study
demonstrates that the surface coating surrounding the AgNP
core signicantly affects the release rate of Ag+ ions. The more
Fig. 6 Percent change in the O.D. of the triangular-shaped Ag-SOA-thiol (blue) and Ag-SOA-PC-thiol (orange) nanoparticles after (A) 1 day and
(B) 21 days of preparation and storage in H2O at 25 C in the dark under aerobic conditions. (C) Representative (C) TEM image and (D) distribution
histogram of triangular-shaped Ag-SOA-PC-HT nanoparticles after 2 months.
Fig. 7 ICP-MS analysis of Ag+ ion release from 1mL samples of (A) spherical AgNPs (1.2 O.D.) and (B) triangular shaped-AgNPs (0.8 O.D.) with Ag-
Cit (blue), Ag-SOA-PC (orange), Ag-SOA-PC-PT (green), and Ag-SOA-PC-HT (yellow) compositions in stored in the dark aerobically in H2O at
25 C after initial synthesis, 24 h, and 1 week.

































































































shielded the AgNPs, the more stable, and less prone to surface
oxidation. Overall, AgNP platforms can be ranked from least
shielded (less stable) to more shielded (more stable) in the
following order of decreasing Ag+ ion release: Ag-Cit < Ag-SOA-
PC < Ag-SOA-PC-PT < Ag-SOA-PC-HT # Ag-SOA-PC-DT.
Effect of chloride ions, pH, and thiolates on nanoparticle
stability
AgNPs are incorporated into many different commercially
available products that end up in environments where they can
pose environmental and human health risks. Besides, since
AgNPs can also be employed in biomedical applications their
stability under physiologically relevant conditions is important.
It is well-known that AgNP aggregation and destabilization is
highly dependent on the surface coating and the environment
that they are exposed to.101–103 Most AgNPs suspensions are
destabilized and are unstable in media containing thiols,
disuldes, and high CaCl2 or NaCl concentrations in the
millimolar range as well as polysaccharides and proteins as they
occur in freshwaters or biological media.101,104–110 In cellular
environments AgNPs are taken up in lysosomes aer phagocy-
tosis, where the potential to release of Ag+ ions is greater at
lower pH.111–113 Furthermore, in toxicological studies aggrega-
tion signicantly affect the dose–response, nature of the toxi-
cant (AgNPs vs. aggregated AgNPs), and exposure route. While
protective surface coatings can stabilize AgNPs, it is important
to test and monitor AgNP aggregation and the rate of Ag+
dissolution, which is dependent on pH,103,114 presence of
thiols,115,116 surface coating, size of the AgNPs,117 and increase in
O2 content.103,118 Therefore, to test the stability and robustness
of Ag-SOA-PC-HT, samples were monitored over time aer
exposure to sources of chlorides, disuldes, thiolates, and
varying pH conditions. For these studies, puried Ag-SOA-PC-
HT was used to ensure free ligands (citrate, lipids, thiols, etc.)
that could play a role in aggregation or surface oxidation is
completely removed. Prior to purication, CN etch test
conrmed that the triangular-shaped Ag-SOA-PC-HT are stable
and completely shielded from surface oxidation.
To investigate the stability of Ag-SOA-PC-HT at low pH
conditions, 1 mL aliquots of triangular-shaped Ag-SOA-PC-HT
at 0.8 O.D. were exposed to 2 M HCl until the pH decreased to
7 or 5 and changes in the LSPR and the O.D. monitored at aer 1
and 24 h. The stability of the AgNPs is studied at pH 5 to
simulate lysosomal uid and tumor microenvironments where
AgNPs reside. At pH 7 very minimal change in O.D. and LSPR is
observed, indicating that the hybrid lipid-coated AgNPs are
stable at physiologically relevant pH (Fig. 8A). However, at pH 5,
a noticeable decrease in the O.D., 36% aer 1 h and 53% aer
24 h are observed (Fig. 8A), which indicates that the Ag-SOA-PC-
HT is aggregating. There is also a slight blue-shi (7%) in the
LSPR band at pH 5, suggesting that the Ag-SOA-PC-HT is also
undergoing a minimal amount of Ag+ ion dissolution within the
rst hour and does not change to any signicant degree aer
24 h (Fig. S6†). This species that the Ag-SOA-PC-HT is relatively
stable at low pH and does not undergo any rapid and signicant
surface oxidation and Ag+ ion release. Evidence of aggregation
is further conrmed by visible dark precipitates that are
observed when the zwitterionic polar head groups are proton-
ated making the Ag-SOA-PC-HT nanoparticles less soluble. The
instability due to aggregation is more evident by the signicant
decrease in the O.D. when the pH drops to pH 2 (Fig. S6†). In
contrast, AgNPs with Cit and SOA-PC are not stable in the
presence of 2 M HCl, which aggregate and undergo Ag+ ion
dissolution rapidly. The hybrid lipid coating anchored with PT
or DT shields the AgNPs from undergoing rapid Ag+ ion disso-
lution that is observed with elemental Ag-based nanoparticles
and Ag2S nanoparticles coated with a lipid and lipid-PEG layer
that leach more Ag+ at lower pH.70,103,119 Consequently, the
relative stability at physiological and pH 5 introduces Ag-SOA-
PC-HT nanoparticles as a potential platform for bioimaging or
drug delivery applications lessening concerns that the AgNPs
will undergo Ag+ ion dissolution in lysosomal compartments
once taken up into cells and induce toxicity.
To investigate the stability of Ag-SOA-PC-HT under high
ionic strength conditions, 1 mL aliquots of triangular-shaped
Ag-SOA-PC-HT at 0.8 O.D. were exposed to varying NaCl and
CaCl2 concentrations and the change in the LSPR and O.D.
monitored aer 1 and 24 h. Upon exposure to increasing
concentrations of NaCl (50–150 mM), Ag-SOA-PC-HT shows a 2–
14% decrease in the O.D. within 1 h and an 11–52% decrease in
O.D. within 24 h (Fig. 8B). A minimal shi (<1%) in the LSPR
band over increasing concentrations is observed indicating no
Fig. 8 Percent change in the O.D. of the triangular-shaped Ag-SOA-PC-HT after 1 h (orange) and 24 h (blue) upon varying (A) the pH (5 and 7)
and (B) concentrations of NaCl from 50 mM to 150 mM in H2O at 25 C.

































































































change in the size or shape of the AgNPs within 1 h (Fig. S7†).
Similarly, when 50 mM of CaCl2 is added to puried Ag-SOA-PC-
HT, a 16% decrease in the O.D. and very small red-shi in the
LSPR band (0.7%) is observed within 1 h (Fig. S8†) indicating
AgNP aggregation. The observed aggregation in the presence of
50 mM of CaCl2 is consistent with other studies where Ca
2+ is
known to interact with the phosphate groups of lipids and
carbonyl groups of the polar head group.120–124 Consequently, it
is expected that under high concentrations of Ca2+ bridging
interactions between Ca2+ and lipid-coated AgNPs occur,
leading to AgNP aggregation that is somewhat reversible in the
presence of EDTA (Fig. S8†). The lack of change in the LSPR
band, with increasing concentrations of NaCl (>50 mM), indi-
cates that Ag-SOA-PC-HT is aggregating under high salt
concentrations. That is, a lack of a blue-shi in the LSPR band
suggests that there is no surface oxidation and shape conver-
sion of the triangular Ag-SOA-PC-HT as a result of Ag+ ion
release caused by Cl etching at high energy points.110,125 The
robust nature of the shielded Ag-SOA-PC-HT nanoparticles is
a physicochemical feature that is important for future use in
vivo, toxicological assessment, and for minimizing the effect of
Ag+ ions released form AgNPs in the environment.
In contrast, these observations differ signicantly from that
of spherical and triangular citrate-capped AgNPs that readily
etch in the presence of 50 mM NaCl, resulting in rapid and
dramatic changes to both the LSPR and O.D. (Fig. 9(A and D))
and a change in color from yellow (spherical) or blue (trian-
gular) to colorless (Fig. S9†). The rapid change in the LSPR and
O.D. is indicative of Cl ion oxidation of Ag0 to Ag+ ions.55,59
Citrate capping agents offer no protection to Cl oxidation of
the AgNPs. The triangular and spherical Ag-Cit-SOA-PC without
thiols underwent slower surface oxidation and Ag+ ion disso-
lution. For the spherical Ag-Cit-SOA-PC a dramatic 26%
decrease in the O.D. and loss of intensity of a golden yellow to
a pale yellow color is observed aer 1 week indicating surface
oxidation (Fig. 9(B, E) and S9(E)†). The triangular Ag-Cit-SOA-PC
Fig. 9 UV-vis spectra of spherical (A) Ag-Cit, (B) Ag-Cit-SOA-PC, (C) Ag-Cit-SOA-PC-HT and triangular (D) Ag-Cit, (E) Ag-Cit-SOA-PC, (F) Ag-
Cit-SOA-PC-HT in the absence and presence of 50 mM of NaCl in H2O at 25 C after 1 h, 24 h, and 1 week.

































































































nanoparticles showed a 150 nm blue-shi in the LSPR band and
a 41% decrease in the O.D. aer 1 week and a change in color
from dark blue to purple aer 1 hour and lighter shades of
purple aer 24 hours to 1 week (Fig. 9(B, E) and S9(F)†). This
change in O.D., LSPR, and color is indicative of surface oxida-
tion and shape conversion from triangles to large spherical-
shaped AgNPs or complete decomposition. The AgNPs with
SOA and PC offered more protection with slower Ag+ ion release
over time compared to citrate ligands (Fig. 9(B and E)). Not
surprisingly, the spherical and the triangular-shaped hybrid
lipid-coated Ag-Cit-SOA-PC-HT had minimal or no change in
LSPR, O.D., or color conrming that the hybrid lipid membrane
shields the surface from oxidation by Cl ions and Ag+ ion
release and is consistent with that observed in the presence of
CN (Fig. 9(D and F)).
Lastly, to evaluate the stability of the Ag-SOA-PC-HT nano-
particles in the presence of thiolates and disuldes, which are
found in biological environments in high concentrations and
can increase the dissolved concentrations of free Ag+ ions,
samples were exposed to biological thiolates.115 Briey, 1 mL
samples of Ag-SOA-PC-HT of 0.8 O.D. were exposed to reduced
glutathione (GSHred) or oxidized glutathione (GSHox) and the
UV-Vis spectrum recorded (Fig. 10). Aer 1 h of exposure to
GSHox, a 33% decrease in O.D. is observed while a 16% decrease
in O.D. is observed in the presence of GSHred. Aer 24 h, there
was an additional 30% decrease in O.D. for GSHox and GSHred.
While an overall decrease in the O.D. was observed for Ag-SOA-
PC-HT, there was a minimal shi in the LSPR band, indicating
that there is some slight aggregation of Ag-SOA-PC-HT nano-
particles. More importantly, there was no evidence that
a chemical reaction between the AgNPs and the GSHox occurred
to oxidize the surface of the Ag-SOA-PC-HT to release Ag+ ion
and form GSHred. These results suggest that the tight
membrane packing around the AgNP core shields the surface
from direct contact of GSHox with the AgNP surface oxidation
further demonstrating that the Ag-SOA-PC-HT is a robust plat-
form for biological applications.
Conclusions
Here robust hybrid lipid-coated AgNPs comprised of a lipid
membrane anchored by long-chained hydrophobic thiols were
synthesized using a layer-by-layer assembly approach. The
approach uses natural lipids as biocompatible capping ligands
to shield the AgNP core from surface oxidation, Ag+ ion release,
aggregation, and shape conversion. Furthermore, for the rst
time, this strategy allows for the design of stable and soluble
AgNPs that are “shaped-locked” so there is no shape conversion
or degradation of the AgNPs where the AgNPs would lose their
unique optical, electronic, or catalytic properties that are based
on shape or size.
The robustness of the Ag-SOA-PC-HT nanoparticles, as
interrogated by CN etch studies, demonstrates that the
membrane encapsulating the AgNP completely covers the AgNP
core protecting it from surface oxidation even in the presence of
membrane disrupting surfactants such as Tween®20. UV-Vis
and ICP-MS studies conrm that the protective coating
shields the AgNPs from surface oxidation over months with no
Ag+ ion release even under harsh biological and environmental
media conditions containing sources of chlorides, thiolates,
disuldes, and low pH. The robustness of the AgNPs is depen-
dent on the rigidity of the surface coating surrounding the
AgNPs, and can be ranked in the order of stability from least
shielded (less stable) to more shielded (more stable) in the
following order: Ag-Cit < Ag-SOA-PC < Ag-SOA-PC-PT < Ag-SOA-
PC-HT # Ag-SOA-PC-DT. Their incredible stability is depen-
dent on the chain-length of the thiol, where AgNPs with short-
chained thiol anchors are less stable than those with long-
chained hydrophobic thiols.
Because the rigidity of the membrane composition can be
tuned to control Ag+ ion release, opportunities exist for greater
control of Ag+ ion release over time, an important feature of
antimicrobial agents embedded in textiles, food packaging,
bandages, and stents. For the rst time, robust lipid-coated
AgNP platforms of varying sizes and shapes that do not
undergo surface oxidation and Ag+ ions are available for use in
toxicological studies. These platforms now make it possible to
evaluate and elucidate how the physicochemical features, size,
shape, surface, coating, surface area, play a role in nanomaterial
toxicity and nanoparticle–biological interactions. That is, how
the physical properties of silver nanomaterials impact human
health and ecotoxicity.
Lastly, these types of robust platforms are ideal for use as
safe and biocompatible X-ray imaging and OCT contrast agents
Fig. 10 Percent change in the (A) O.D. and (B) LSPR band of the triangular-shaped Ag-SOA-PC-HT nanoparticles before (blue) and after the
addition of 50 mM GSHox (orange) and GSHred (green) after 1 h and 24 h in H2O at 25 C.

































































































whose optical and physical properties are not expected to
change because of surface oxidation in biological environ-
ments. The lipid membrane composition of hybrid lipid-coated
AgNPs can be easily modied by conjugation to incorporate
cleavable molecular drugs, MRI contrast agents, or uorescent
molecules for bimodal imaging. Consequently, this facile
surface modication makes this platform much more multi-
functional and versatile for a range of biomedical applications
without the concern of toxic Ag+ ions being released from the
surface that can impact human health compared to existing
AgNP platforms. That is, the design strategy is exible and can
be adapted for any shape and size of AgNP with any membrane
composition, allowing for small libraries of nanoparticles to be
produced for varying biomedical and commercial applications.
Methods and materials
Reagents
95% L-a-phosphatidylcholine (PC), sodium borohydride
(NaBH4), trisodium citrate (Na3C6H3O7), 1-decanethiol 96%
(DT), 1-hexanethiol 95% (HT), and 1-propanethiol 99% (PT),
Tween®20, gluthathione reduced (GSHred) and oxidied (GSHox)
are from Sigma Aldrich. Sodium oleate (SOA) 97% is purchased
from Tokyo Chemistry Industry Co, Ltd. Silver nitrate (AgNO3) is
from G. Frederick Smith Chemical Co. and potassium cyanide
(KCN) is from Mallinckrodt, while 30% Hydrogen Peroxide is
from BDH Chemicals. All chemicals were used as received.
Nanopure water was from a Milli-Q ultra-pure system. Ultra-
centrifugation was performed with a Thermo Scientic, Sorvall
ST 40R at 4700 rpm using Vivaspin ultracentrifuge concentra-
tors with a PES membrane (Vivaspin 20, MWCO ¼ 10k).
Preparation of silver nanoparticles
Using a modied procedure, AgNO3 (43 mL of a 0.109 mM in
H2O) is combined with H2O2 (120 mL of 30% w/w) and
Na3C6H3O7 (3.68 mL of a 34.2 mM in H2O) in a 250 mL Erlen-
meyer ask covered with aluminum foil to protect the solution
from light exposure. The mixture is allowed to stir at 600 rpm
with a medium-sized stir bar for approximately 1 min before
a freshly prepared aqueous solution of NaBH4 (360 mL of
100 mM in H2O) is rapidly added to the center of the reaction
vortex in the ask. NaBH4 addition to the solution results in
a rapid color change for approximately 2–3 min changing from
pale yellow to orange, to purple, and nally, a blue color that is
indicative of triangular silver nanoplates (AgNPLs). The result-
ing solution is allowed to stir for an additional 10 min before it
is covered and stored in the refrigerator at 4 C overnight. The
same procedure was employed to form silver nanospheres
(AgNSs) and nanorods (AgNRs), with the volume of NaBH4
reduced to 110 mL and 160 mL, respectively.
Preparation of PC-coated silver nanoparticles (Ag-OA-PC-HT)
To citrate-capped AgNPs (1 mL of nanoparticles of O.D. 1.2 at
lmax 705 nm in H2O) was added a solution of SOA (1.1 mL of
a 9.4 mM in H2O) in an Eppendorf. The Ag-citrate-SOA solution
was vortexed for 5 s and allowed to incubate for 20 min. This is
followed by the addition of PC liposomes (10.4 mL of 0.32 mM in
10 mM sodium phosphate buffer pH 8) that was incubated with
the Ag-SOA for 40 min aer 5 s of vortex mixing. The PC lipo-
some was prepared using a well-established method where
a solution of PC (100 mL of 3.3mMCHCl3) was evaporated under
a stream of N2 as a thin lm and placed under a vacuum of 12 h
to remove trace organic solvents. The lm was resuspended in
1mL of 10mM sodium phosphate buffer pH 8 and sonicated for
90 min until the solution was clear. To the Ag-citrate-SOA-PC
solution was added a fresh solution of hexanethiol (1.4 mL of
a 30 mM solution in ethanol) that were incubated for
a minimum of 30 min before use. HT can be substituted for an
equivalent amount of PT or DT to produced Ag-SOA-PC-PT or
Ag-SOA-PC-HT nanoparticles. Because of their robust nature,
the Ag-SOA-PC-HT or Ag-SOA-PC-DT nanoparticles can be
puried to remove free citrate, PC, and SOA by incubating each
1 mL of hybrid-coated AgNPs with 10 mL of 10 mM of Tween®20
for 1 h before ultracentrifugation at 4700 rpm, using a Vivaspin
20 column (3  10 mL of H2O).
Stability studies in the presence of cyanide, chloride salts,
Tween®20, glutathione, and pH
To determine if the surface of the AgNPs are shielded from
oxidation, we performed well-known cyanide (CN) etch test.99 A
1 mL solution of triangular-shaped Ag-SOA-PC-HT (O.D. 1.2) is
incubated with 20 mL of the 307 mM KCN in an Eppendorf for
1 h. The UV-Vis spectra were collected before and aer the
addition of KCN and the change in the O.D. and lmax
monitored.
Long-term storage stability was evaluated by storing stock
solutions of spherical (O.D. 0.8) and triangular-shaped (O.D.
1.0) Ag-SOA-PC-HT in the dark at 25 C. From these samples,
1 mL aliquots of AgNPs were retrieved and centrifuged using
a Vivaspin column with PES membrane and MWCO of 3 kDa.
Samples were centrifuged at 4700 rpm for 4min and the ltrates
collected for ICP-MS analysis at upon initial preparation, 24 h,
and 1 week. The UV-Vis spectra were collected over time and the
change in the O.D. and lmax monitored.
To evaluate the stability of triangular-shaped Ag-SOA-PC-HT
nanoparticles in the presence of membrane disrupting surfac-
tants, chloride salts, pH, and biological thiols, 1 mL samples of
AgNPs were incubated with Tween®20, NaCl, CaCl2, GSHred or
GSHox and the pH varied between 2–8. To test the effect of
membrane disrupting surfactants, 1 mL of triangular-shaped
Ag-SOA-X or Ag-SOA-PC-X (O.D. ¼ 1.0) (X ¼ PT, HT, or DT) in
10 mM sodium phosphate buffer pH 8 were incubated with 20
mL of 10 mM Tween®20 for a nal concentration 0.2 mM in the
dark at 25 C and allowed to incubate for 24 h before the
addition of 20 mL of 307 mM KCN. The UV-Vis spectra were
recorded before and aer 1 week of KCN addition. To evaluate
the effect of chlorides, 1 mL of triangular-shaped Ag-SOA-PC-HT
(O.D. 0.8) was exposed to NaCl or CaCl2 to yield nal concen-
trations of 50 mM, 100 mM, or 150 mM. To understand if the
interactions of the nanoparticles exposed to CaCl2 are revers-
ible, 100 mL of 500 mM EDTA was added to the Ag-SOA-PC-HT
nanoparticles exposed to 50 mM CaCl2. Alternatively, to

































































































evaluate the effect of pH on nanoparticle stability, 1 mL of 2 M
HCl was added to 1 mL of triangular-shaped Ag-SOA-PC-HT (0.8
O.D.) to adjust the pH to 5, respectively from an initial pH 7–8.
To evaluate the effect of biological thiols, 160 mM of GSHred and
GSHox was added to 1 mL of triangular-shaped Ag-SOA-PC-HT
(0.8 O.D.) to yield a nal concentration of 50 mM. Due to
solubility constraints, the stock solution of GSHox was prepared
in 10 mM sodium phosphate buffer at pH 8 and the GSHred
stock was prepared in nanowater. The percent change in the
O.D. or LSPR was monitored by taking a UV-Vis spectrum before
and aer the addition of NaCl, CaCl2, GSHred and GSHox,
Tween®20, and varying pH.
Transmission electron microscopy (TEM) and UV-Vis
spectroscopy
Samples were prepared by drop-casting dilute solutions of
AgNPs onto carbon-coated (300 Å) Formvar lms on copper
grids (Ted Pella). Samples sat for 5min before the excess sample
is wicked off by with a piece of lter paper and the process was
repeated 3 times. Transmission electron micrographs were
acquired on a Tecnai F-20 FEI microscope using a CCD detector
at an acceleration voltage of 200 kV. AgNP size and shape
analysis were performed using ImageJ soware. Absorbance
measurements were performed with an Ocean Optics USB2000
UV-visible spectrophotometer using a 1.0 cm path length quartz
cell.
ICP-MS studies
ICP-MS measurements were performed in the OHSU
Elemental Analysis Core with partial support from the NIH
instrumentation grant S10RR025512. Samples of AgNPs (1 : 9
ratio of AgNPs and H2O) were prepared. Samples were diluted
into 15 ml metal-free polypropylene tubes (VWR 89049-170
series) in the Client's lab. All samples, controls, calibration
standards, and rinses were prepared in 1% HNO3 (trace metal
grade, Fisher)/0.5% HCl (trace metal grade, Fisher). ICP-MS
analysis was performed using an Agilent 7700x equipped
with an ASX 500 autosampler. The system was operated at
a radio frequency power of 1550 W, an argon plasma gas ow
rate of 15 L min1, Ar carrier gas ow rate of 0.9 L min1. Silver
was measured in NoGas mode. Data were quantied using
a 10-point (0, 0.5, 1, 2, 5, 10, 20, 50, 100, 500 ppb (mg kg1))
calibration curve using a single-element standard (Ag, (VHG-
LAGN-100, Lot # 404-0117-1)) in 1% HNO3/0.5% HCl. For
each sample, data were acquired in triplicates and averaged. A
coefficient of variance (CoV) was determined from frequent
measurements of a sample containing10 ppb Ag. An internal
standard (Sc, Ge, Bi) continuously introduced with the sample
was used to correct for detector uctuations and to monitor
plasma stability. Accuracy of the calibration curve was
assessed by measuring NIST reference material (water, SRM
1643f) and found to within 5% of the expected value for Ag in
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TEM Transmission electron microscopy
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E. S. Kamimura, C. H. Corassin and C. A. F. d. Oliveira,
Application of silver nanoparticles in food packages:
a review, Food Sci. Tech., 2019, 39, 793–802.
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